NeelAgil Technologies

We provide oral protein technology to improve the patients life.

About Us

Publications

image246

  1. Minnesota Microscopy Society, University of Minnesota, USA, 2011 (Best Poster).
  2. Journal of Nanoparticles, 2010 (Article ID 652048).
  3. Langmuir, 2010, Vol. 26 (1), pp. 357-361. 
  4. J. Phys. Chem. B, 2009, Vol. 113 (42), pp. 13782-13787.
  5.  NSTI NanoTech, The Nanotechnology Conference and Trade Show, Nanotech 2008, Boston, USA. 

Oral Insulin

image247

 We developed oral insulin technology for insulin dependent diabetes patients. The invention is going to help million of diabetes patients around the world by providing painless and cost-effective therapy. 

Unite for Diabetes

image248

Insulin deficiency causes a disease called diabetes mellitus and hence, administration of exogenous insulin is used to control this disease. The complications of uncontrolled diabetes include blindness, kidney failure, stroke, neuropathy & amputations. It has been recorded by WHO that 422 million people have diabetes in the world and it lead to 4.9 million deaths in 2014. Every year 70,000 children are developing type 1 diabetes around the world and they need to take 2-4 insulin injections in a day. 

Our Target: oral insulin Tablet

Awards & Recognition

image249

AIT- Swissnex 2018

AIT-Swissnex 2018



TiE Delhi- Jerusalem

image250